Search This Blog

Wednesday, January 3, 2024

Agios' blood disorder drug meets goals of late-stage study

 Agios Pharmaceuticals said on Wednesday its drug met the main and secondary goals in a late-stage study in patients with an inherited blood disorder.

https://finance.yahoo.com/news/agios-blood-disorder-drug-meets-114036759.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.